Vaccines

Politics By Mark Sherman and Jessica Gresko — Associated Press

Supreme Court halts Covid-19 vaccine rule for U.S. businesses

In the Lab By Megan Molteni

Strong new evidence suggests a virus triggers multiple sclerosis

Health By Andrew Joseph, Helen Branswell, Nicholas Florko and Lev Facher

13 big questions about Biden’s response to Omicron, as Congress prepares to grill Fauci, Walensky, and other top officials

Politics By Mark Sherman and Jessica Gresko — Associated Press

Supreme Court skeptical of Biden’s workplace vaccine rule

Pharmalot By Ed Silverman

Institutional investors urge pharma boards to tie executive compensation to global Covid vaccine equity

First Opinion By Patrick Skerrett

5 most widely read First Opinion essays of 2021

Pharmalot By Ed Silverman

Pharmalittle: Japan panel nixes Biogen Alzheimer’s drug; Oxfam urges SEC to probe Moderna over patent dispute remarks

Health By Helen Branswell

3 issues to watch in global health in 2022

First Opinion By Azfar Hossain, Stephen Asiimwe and Louise Ivers

Claims of vaccine hesitancy in African countries are at odds with the reality on the ground

Pharmalot By Ed Silverman

Facing intense criticism, Moderna pauses bitter dispute with the NIH over Covid-19 vaccine patents

Matt's Take By Matthew Herper

The tragedy of Johnson & Johnson’s Covid vaccine

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Listen: Covid in 2022, J.P. Morgan bows to pressure, & the year in review

Pharmalot By Ed Silverman

STAT/HarrisPoll: Omicron is forcing Americans to rethink some — but not all — of their holiday plans

Health By Nicholas St. Fleur

Leading Covid-19 experts on the questions they want answered about Omicron

Health By Andrew Joseph

CDC data indicate Omicron is starting to eat into Delta’s U.S. dominance

Health By Olivia Goldhill

We have enough Covid vaccines for most of the world. But rich countries are stockpiling more than they need for boosters

First Opinion By Geeta Nayyar

Vaccine skepticism is healthy. Cynicism is not

Health By Andrew Joseph

The Omicron variant can likely outcompete Delta — and that could worsen the U.S. Covid-19 epidemic

First Opinion By Seth Berkley

Vaccine equity is essential. Vaccine makers need to drop barriers to reaching refugees and other displaced people

First Opinion By Ingrid Katz and Abraar Karan

Ending the pandemic requires global solidarity, not blame

Health By Andrew Joseph and Helen Branswell

A first, small study suggests Omicron is a larger threat to Covid-19 immunity than other variants

Health By Helen Branswell

Early data from South Africa hints Omicron variant may cause less severe Covid, but more research is needed

In the Lab By Andrew Joseph

We’ll know more soon about Omicron. Here’s how to interpret the coming flood of data

First Opinion By Jeffrey E. Harris

The Fifth Circuit Court got the science wrong on OSHA’s vaccination mandate

Health By Andrew Joseph

Doctors hope Omicron causes milder cases of Covid — but it’s still too early to say